Form 8-K - Current report:
SEC Accession No. 0001615219-23-000027
Filing Date
2023-03-13
Accepted
2023-03-13 08:55:30
Documents
12
Period of Report
2023-03-10
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K flks-20230310.htm   iXBRL 8-K 32697
  Complete submission text file 0001615219-23-000027.txt   167328

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20230310.xsd EX-101.SCH 1924
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20230310_lab.xml EX-101.LAB 23892
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20230310_pre.xml EX-101.PRE 12541
6 EXTRACTED XBRL INSTANCE DOCUMENT flks-20230310_htm.xml XML 11337
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 23725885
SIC: 2834 Pharmaceutical Preparations